6.Clinical trials conducted between regulatory submission of an NDA (New Drug Application) and approval of a regulatory dossier for marketing authorization.
7.CEPs can be used by companies when submitting an application for marketing authorisation, and replaces much of the documentation required for the active substance in the marketing authorisation dossier.
